39th week of 2009 patent applcation highlights part 47 |
Patent application number | Title | Published |
20090240026 | Novel Fluorescent Amino Acid Derivative and Production Method Of The Same - An object of the present invention is to provide a novel fluorescent amino acid derivative which can be synthesized by simple steps, can be excited particularly by a blue laser ray region of visible light, and has an improved light stability. Another object is to provide a production method of the fluorescent amino acid derivative. These objects can be achieved by a fluorescent amino acid derivative which is an acridone derivative substituted with an amino acid to comprise an electrophilic substituent group between the amino acid and the acridone derivative. Instead of a conventional strategy that aminophenylalanine is used as a starting material to form a fluorescent group through a coupling reaction and an intramolecular cyclization reaction, a fluorescent acridone derivative is used as a starting material to furnish the material to a reactive group by a position-specific electrophilic substitution reaction, and then the acridone derivative having the reactive group is allowed to couple with an amino acid derivative. | 2009-09-24 |
20090240027 | INTERMEDIATES FOR MACROCYCLIC COMPOUNDS - The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates: | 2009-09-24 |
20090240028 | Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for Peptides - The invention provides synthesis and application of new structural well defined branched polymers as protraction agents for peptide and protein. | 2009-09-24 |
20090240029 | Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides - Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one heterocycle, aldol-based, dicarbonyl, and/or diamine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one heterocycle, aldol-based, dicarbonyl, and/or diamine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses. | 2009-09-24 |
20090240030 | Biomolecular coupling methods using 1,3-dipolar cycloaddition chemistry - This invention provides methods for covalently affixing a biomolecule to either a second molecule or a solid surface using 1,3-dipolar cycloaddition chemistry. This invention also provides related methods and compositions. | 2009-09-24 |
20090240031 | Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments - The invention relates to a process for the preparation of cardiodilatin fragments, to highly purified cardiodilatin fragments, and to appropriate intermediates for the preparation of said fragments. Furthermore, the invention relates to highly purified cardiodilatin fragments which are free of peptide impurities and exhibit a single migration peak in capillary electrophoresis, as well as to appropriate processes for the preparation of same. | 2009-09-24 |
20090240032 | Novel sugar-immobilized metal nanoparticle, method for measuring sugar-protein interaction using the same and method for recovering protein from sugar-protein interactant - It is intended to provide a stable novel sugar-immobilized metal nanoparticle capable of easily immobilizing a sugar chain, a method for measuring sugar-protein interaction easily and at a low cost using the same without labeling, and a method for simply recovering a protein from a sugar-protein interactant. A maltose-immobilized gold nanoparticle was obtained by binding a ligand complex, in which maltose and a linker compound had been bound to each other, to a gold nanoparticle. By adding this maltose-immobilized gold nanoparticle to a dilution series of concanavalin A, a sugar-protein interactant of maltose and ConA was formed, and red-purple color derived from a colloidal solution of maltose-immobilized gold nanoparticle disappeared. That is, sugar-protein interaction could be confirmed by visual observation without labeling. | 2009-09-24 |
20090240033 | AFFINITY MATRIX LIBRARY AND ITS USE - The invention relates, at least in part, to an affinity matrix library and the construction and use thereof. The library may be used, for example, for the enrichment of low-abundance proteins and depletion of abundant proteins in the search for biologically important proteins. The present invention also relates to a synthetic affinity matrix library comprising one or more ligand compounds with groups selected from amino, sulfhydryl, hydroxyl, carbonyl, and/or active hydrogen. The ligand compound may be attached to a base matrix. | 2009-09-24 |
20090240034 | METHOD FOR PRODUCING PEPTIDE THIOESTER - It is an object of the present invention to provide a novel method for producing a peptide thioester. In the present invention, general peptide synthesis is performed on a solid-phase resin, carboxylic acid obtained after cutout is allowed to react with p-toluenesulfonyl isocyanate, and then the reaction product is alkylated, and is reacted with thiol. Thus, peptide thioester is simply synthesized under mild conditions. | 2009-09-24 |
20090240035 | DNA REPLICATION PROTEINS OF GRAM POSITIVE BACTERIA AND THEIR USE TO SCREEN FOR CHEMICAL INHIBITORS - The present invention relates to alpha-large, alpha-small, delta, delta prime, tau, beta, SSB, DnaG, and DnaB encoding genes from Gram positive bacterium, preferably | 2009-09-24 |
20090240036 | Anti-IL-23 Antibodies - The present invention encompasses isolated antibodies, or antigen-binding portions thereof, that specifically bind to the p19 subunit of IL-23. These antibodies, or antigen-binding portions thereof, are high affinity, neutralizing antibodies useful for the treatment of autoimmune disease. | 2009-09-24 |
20090240037 | HUMANIZED ANTIBODIES AND METHODS OF HUMANIZING ANTIBODIES - Humanized, chimeric and human anti-CD20 antibodies and CD20 antibody fusion proteins that bind to a human B cell marker, referred to as CD20, which are useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies and autoimmune diseases, and methods of treatment and diagnosis are disclosed. Methods of making the humanized, chimeric and human anti-CD20 antibodies are disclosed. A humanized anti-HSG (histamine-succinyl-glycyl) monoclonal antibody designated h679 which binds with high affinity to molecules containing the moiety histamine-succinyl-glycyl (HSG), and methods of making the humanized anti-HSG antibody also are disclosed. | 2009-09-24 |
20090240038 | ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF - The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to EGFRvIII. Diagnostic and therapeutic formulations of such antibodies, and immunoconjugates thereof, are also provided. | 2009-09-24 |
20090240039 | Polypeptide fusion - A hybrid protein includes two coexpressed amino acid sequences forming a dimer. Each sequence contains the binding portion of a receptor, such as TBP1 or TBP2, or a ligand, such as IL-6, IFN-β and TPO, linked to a subunit of a natural heterodimeric scaffold. Each coexpressed sequence contains a corresponding subunit so as to form a heterodimer upon expression. Corresponding DNA molecules, expression vectors and host cells are also disclosed as are pharmaceutical compositions and a method of producing such proteins. | 2009-09-24 |
20090240040 | PURIFICATION OF A BIVALENTLY ACTIVE ANTIBODY USING A NON-CHROMATOGRAPHIC METHOD - The present invention discloses a method of purifying bivalent antibodies or antibody fragments that are active at both Fab sites from a source of antibodies or antibody fragments using a non-chromatographic method that includes inducing the formation of cyclic immunoglobulin aggregates by addition of multivalent hapten to a salt solution of soluble antibodies or antibody fragments, wherein the multivalent hapten possesses a linker between the two haptens effective to prevent the binding of both haptens of the ligand to the same antibody or antibody fragment. | 2009-09-24 |
20090240041 | TUMOR IMAGING COMPOUNDS - The invention provides novel amino acid compounds of use in detecting and evaluating brain and body tumors. These compounds combine the advantageous properties of α-aminoisobutyric acid (AIB) analogs namely, their rapid uptake and prolonged retention in tumors with the properties of halogen substituents, including certain useful halogen isotopes such as fluorine-18, iodine-123, iodine-124, iodine-125, iodine-131, bromine-75, bromine-76, bromine-77, bromine-82, astatine-210, astatine-211, and other astatine isotopes. In addition the compounds can be labeled with technetium and rhenium isotopes using known chelation complexes. The amino acid compounds disclosed herein have a high specificity for target sites when administered to a subject in vivo. The labeled amino acid compounds are useful as imaging agents in detecting and/or monitoring tumors in a subject by Positron Emission Tomography (PET) and Single Photon Emission Computer Tomography (SPECT). | 2009-09-24 |
20090240042 | ENDOHEDRAL METALLOFULLERENE DERIVATIVES - Trimetallic nitride endohedral metallofullerene derivatives and their preparation are described. The trimetallic nitride endohedral metallofullerene derivatives have the general formula A | 2009-09-24 |
20090240043 | RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF - The present invention is based on the in vivo demonstration that RSV can be inhibited through intranasal administration of iRNA agents as well as by parenteral administration of such agents. Further, it is shown that effective viral reduction can be achieved with more than one virus being treated concurrently. Based on these findings, the present invention provides general and specific compositions and methods that are useful in reducing RSV mRNA levels, RSV protein levels and viral titers in a subject, e.g., a mammal, such as a human. These findings can be applied to other respiratory viruses. | 2009-09-24 |
20090240044 | PROCESS FOR THE REDUCTION OF ENDOTOXINS IN A PLASMID PREPARATION USING A CARBOHYDRATE NON-IONIC DETERGENT WITH SILICA CHROMATOGRAPHY - The present invention provides methods for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography. | 2009-09-24 |
20090240045 | Organic Compounds - A compound of formula (I) or stereoisomers or pharmaceutically acceptable salts thereof, and their preparation and use as pharmaceuticals | 2009-09-24 |
20090240046 | CARBOXYLATED GLUCOSAMINE COMPOUNDS FOR INHIBITING THE ACTIVATION AND EXPRESSION OF MATRIX METALLOPROTEINASE-9 IN HUMAN FIBROSARCOMA CELLS AND MATRIX METALLOPROTEINASE-9 INHIBITORS CONTAINING THE SAME - The present invention relates to the CGlc compound for inhibiting the expression and activation of MMP-9 in HT1080 and the MMP-9 inhibitor comprising the CGlc compound as an effective ingredient, which can inhibits the expression of AP-1 in Ht1080 to effectively inhibit the expression and activation of MMP-9 such that it is effectuated in treating a wound, metastasis, rheumatoid arthritis, inflammation, hyperparathyroidism, diabetes, cornel ulcer, osteoporosis, stomach ulcer, trauma, pimple, burn, periodontal disease, arteriosclerosis or fracture. | 2009-09-24 |
20090240047 | CELLULOSIC RESIN FILM AND PROCESS FOR PRODUCING THE SAME - The invention provides a melt-casting film formation process for a cellulosic resin film, by which thickness unevenness of the cellulosic resin film is suppressed in both the cross-machine direction and machine direction. Consequently the invention can provide a cellulosic resin film having high optical properties. In this process for producing the cellulosic resin film, a resin molten in an extruder ( | 2009-09-24 |
20090240048 | Alpha-crystalline form of substituted selenoxanthenes and the method of its preparation - The invention pertains to field of organic chemistry, medicine, pharmacology, foods and cosmetics industry, particularly, to manufacturing technology of selenoxanthenes; the invention may be used in manufacturing of food supplements, pharmaceutical and cosmetic products, having bioactive properties, of a wide spectrum of activity. The proposed compound is the α-crystalline form of 9-phenyl-symmetrical-octahydroselenoxanthene with exhibits antioxidant, detoxifying, immunomodulating, anti-atherogenic, anti-sclerotic, anabolic and hypolipidemic properties, and has the following structural formula: | 2009-09-24 |
20090240049 | Purification of air sensitive steroids - The present invention provides a purification method for air sensitive steroids, by reacting an amino acid or an analogue thereof with the 21-aldehyde oxidation product of such air sensitive steroids to form an adduct that is separated from the purified air sensitive steroids. | 2009-09-24 |
20090240050 | Method Of Preparing Macrocylic Metal Cyanine Compound - A method of preparing a macrocyclic metal cyanine. The method comprises the step of providing a corresponding macrocyclic metal-free cyanine compound dissolved in a solvent and adding a metal reagent thereto. The metal reagent is highly soluble in the solvent and typically comprises one or more organic ligands. | 2009-09-24 |
20090240051 | New process for the production of oxabispidines - There is provided a process for the preparation of a compound of formula I, | 2009-09-24 |
20090240052 | NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF - An anthranilic acid derivative represented by the general formula (X) [wherein R | 2009-09-24 |
20090240053 | Substituted 2-Aminoacetamides and the Use Thereof - The invention is directed to substituted 2-aminoacetamides represented by formula (II): | 2009-09-24 |
20090240054 | Rosuvastatin calcium with a low salt content - Provided is rosuvastatin calcium with a low salt by product content and processes for preparing such rosuvastatin calcium. | 2009-09-24 |
20090240055 | Method for 1H-Imidazo[4,5-C] Pyridines and Analogs Thereof - Methods and intermediates for preparing compounds of the Formulas: (I and X) are disclosed. The methods include a method providing a compound of the Formula: (IV) and converting a compound of Formula IV to a compound of Formula I, a method providing a compound of the Formula: (VIII) and converting a compound of Formula VIII to a compound of Formula I, and a method providing a compound of the Formula: (XI) and converting a compound of Formula XI to a compound of Formula I. | 2009-09-24 |
20090240056 | METHODS FOR MAKING 4-TETRAZOLYL-4-PHENYLPIPERIDINE COMPOUNDS - Methods, composition, and intermediates are disclosed that are useful for making 4-Tetrazolyl-4-phenylpiperidine Compounds according to Formula I, | 2009-09-24 |
20090240057 | 3,4-Dihalogenoisothiazole Derivative, and Agricultural or Horticultural Plant Disease-Controlling Agent - A 3,4-dihalogenoisothiazole derivative represented by the general formula [I] | 2009-09-24 |
20090240058 | Activator for Peroxisome Proliferator-Activating Receptor Delta - A compound or its salt having the following formula (II) is used as an activator for PPAR δ: | 2009-09-24 |
20090240059 | Monovalent and Divalent Salts of N-(5-Hydroxynicotinoil) -L-Glutamic Acid Exhibiting Psychotropic (Antidepressant and Anxiolytic), Neuroprotective, Geroprotective and Cerebroprotective Action - The invention relates to medicine, in particular to mono- and divalent salts of N-(5-hydroxynicotinoil)-L-glutaminic acid exhibiting psychotropic antidepressant, anxiolytic, heroprotective, neuroprotective, antihypoxia cerebroprotective and nootropic action. The novel compounds differ from the known preparations, including the closest prior art in the form of a N-(5-hydroxynicotinoil)-L-glutaminic acid base (nooglucotyl), in that they produce psychotropic effects, namely antidepressant, anxiolytic, neuroprotective and heroprotective actions, in such a way that lesion focuses caused by apoplectic attacks are reduced and age-specific neurological deficiencies and intellectual and physical work capacities are improved. | 2009-09-24 |
20090240060 | PROCESS FOR THE PREPARATION OF PURE IRBESARTAN - A process for the manufacturing of a pure irbesartan comprising converting irbesartan or a protected derivative thereof into an isolated hydrohalide acid addition salt, whereupon said hydrohalide acid addition salt is converted into the irbesartan is described. | 2009-09-24 |
20090240061 | Method for forming a carbon-carbon or carbon-heteroatom bond - The invention relates to a method for forming a carbon-carbon or carbon-heteroatom bond by reacting an unsaturated compound carrying a leaving group and a nucleophilic compound, in the absence of a ligand. The aim of the invention is especially to form carbon-nitrogen bonds according to a method for the arylation of nitrogenated organic derivatives. According to the inventive method, a carbon-carbon or carbon-heteroatom bond is formed by reacting an unsaturated compound carrying a leaving group with a nucleophilic compound donating a carbon atom or a heteroatom (HE) that can substitute the leaving group, thus forming a C—C or C—HE bond, in the presence of a copper-based catalyst and a base. Said metal is characterised in that the reaction takes place in the absence of a ligand and in a nitrile-type solvent. | 2009-09-24 |
20090240062 | COMPOUND DERIVED FROM CYCLOPENTADIENONE, PREPARATION METHOD THEREOF AND EL ELEMENT USING THE SAME - Disclosed are a compound represented by the following formula (1), which is derived from cyclopentadienone and can be used as a core material for an organic electroluminescence element or other optical devices, and preparation method thereof, and an EL element using the same. | 2009-09-24 |
20090240063 | Process For The Preparation Of 6,6-Dimethyl-3-Azabicyclo-[3.1.0]-Hexane Compounds ... - The present invention provides for a process for preparing racemic methyl 6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylate, its corresponding salt: (2S, 3R, 4S)-methyl 6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylate di-p-toluoyl-D-tartaric acid (“D-DTTA”) salt or a (2R, 3S, 4R)-methyl 6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylate di-p-toluoyl-L-tartaric acid salt (“L-DTTA”) in a high enantiomeric excess. This invention also provides for a process for preparing a (2S, 3R, 4S)-methyl 6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylate dibenzoyl-D-tartaric acid (“D-DBTA”) salt or a (2R, 3S, 4R)-methyl 6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylate L-tartaric acid (“L-DBTA”) salt in a high enantiomeric excess. Further, this invention provides a process for preparing intermediates II, IIB, III, IV, IV salt, V, VI, and VII. | 2009-09-24 |
20090240064 | CRYSTALLINE FORM OF ATORVASTATIN HEMI-CALCIUM - The present invention relates to a new crystalline form of Atorvastatin hemi-calcium and also relates to a process for preparation of the same by treating Atorvastatin hemi-calcium amorphous form or form-I or mixture of amorphous and crystalline forms with methanol. | 2009-09-24 |
20090240065 | BLACK COLOR MATERIAL AND TONER - The black color material includes a condensation product of a pyrrole compound represented by the following formula (1) and a squaric acid represented by the following formula (2): | 2009-09-24 |
20090240066 | INTERMEDIATES FOR THE PRODUCTION OF OPTICALLY ACTIVE CYCLOPROPYLAMINE DERIVATIVES AND PROCESS FOR THE PRODUCTION OF THE INTERMEDIATES - The present invention provides intermediates needed for production of an optically active compound represented by formula (6), which enable the compound (6) to be readily synthesized in simple production steps without optical resolution, and also provides a process for producing the intermediates. | 2009-09-24 |
20090240067 | METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND - A method of producing a compound represented by formula (1), including: allowing 1,4-benzoquinone or 1,2-benzoquinone to react with a dithiocarbamate compound represented by formula (2) in a polar solvent: | 2009-09-24 |
20090240068 | METHODS OF MAKING CYCLODODECATRIENE AND METHODS OF MAKING LAUROLACTONE - The present disclosure provides processes for the preparation of dodecanedioic acid (DDDA). | 2009-09-24 |
20090240069 | Process for preparation of mycophenolic acid and ester derivatives thereof - Provided are processes for preparation of mycophenolic acid. | 2009-09-24 |
20090240070 | WHITENING DERMATOLOGICAL PREPARATIONS - Disclosed is a dermatological preparation that are safe and are excellent in inhibiting and removing skin pigmentation and in inhibiting skin roughness. A dermatological preparation comprising a tocopherol aminoalkylcarboxylate and/or a salt thereof, the tocopherol aminoalkylcarboxylate being represented by Formula (I): | 2009-09-24 |
20090240071 | PREPARATION AND PURIFICATION OF MUPIROCIN CALCIUM - The present invention relates to methods for the preparation and purification of mupirocin calcium. The process comprises adsorbing mupirocin to a hydrophobic adsorbent resin, exposing the bound mupirocin to a calcium-containing solution, washing impurities from the resin and eluting purified mupirocin calcium from the resin. | 2009-09-24 |
20090240072 | Mixing Device for Liquids - The device serves for mixing at least one liquid first and one liquid, viscous or powdery second component which can be introduced into the mixing chamber of a mixing body and, after the mixing process has been carried out, can be removed again from said mixing chamber in the form of the mixed product. According to the invention, the mixing body is a self-contained annular tube system, the interior space of which forms the mixing chamber through which the mixed product can be transported cyclically by means of a conveying element, wherein a plurality of closeable inlet openings for the feed of the components and at least one closeable outlet opening for the removal of the mixed product are provided in the mixing body. The device is suitable for the admixing of reactive components. In particular, it is suitable for the production of aqueous silanes. | 2009-09-24 |
20090240073 | METHOD FOR DETOXIFYING PHOSPHONATE HERBICIDES - The invention relates in general to methods for detoxifying phosphonate herbicides. The methods may comprise transacetylating the phosphonate herbicide. The phosphonate herbicides can comprise a CP bond and a CN bond and may be glyphosate. | 2009-09-24 |
20090240074 | Process Of Making Optically Pure Melphalan - This invention provides a process of making 4-(bis-(2-hydroxyethyl)amino)-L-phenylalanine of the formula | 2009-09-24 |
20090240075 | SHAPE MEMORY MAIN-CHAIN SMECTIC-C ELASTOMERS - Shape memory main-chain smectic-C elastomers are described, as are methods for their preparation and monomers used in such methods. The elastomers are prepared by hydrosilylation of a reaction mixture including a liquid crystalline diene, a crosslinking agent, and a bis(silyl hydride) compound. The elastomers exhibit shape-memory properties and spontaneously reversible shape changes. They are useful for fabrication of shape memory articles including, for example, implantable medical devices, contact lenses, reversible embossing media, and Fresnel lenses. | 2009-09-24 |
20090240076 | PROCESS FOR PREPARING METHYLENEDIPHENYL DIISOCYANATES - The invention relates to a process for preparing methylenediphenyl diisocyanates which comprises at least the steps: A) reaction of aniline with formaldehyde in the presence of hydrochloric acid as catalyst to give a mixture of diamines and polyamines of the diphenylmethane series (MDA) and subsequent at least partial neutralization of the hydrochloric acid by means of alkali metal hydroxide, B) reaction of the mixture of diamines and polyamines of the diphenylmethane series obtained in step A) with phosgene to give a mixture of diisocyanates and polyisocyanates of the diphenylmethane series (MDI) and hydrogen chloride, wherein C) the hydrochloric acid which has been neutralized in step A) is separated off in the form of a solution containing alkali metal chloride and is subsequently at least partly fed to an electrochemical oxidation to form chlorine, alkali metal hydroxide and optionally hydrogen and D) at least part of the chlorine produced in step C) is used for preparing the phosgene used in step B). | 2009-09-24 |
20090240077 | PROCESS FOR PRODUCING DIAMINES AND POLYAMINES OF THE DIPHENYLMETHANE SERIES - The present invention relates to a process for producing diamines and polyamines of the diphenylmethane series (MDA) by reacting aniline and formaldehyde in the presence of an acid catalyst, wherein the aniline contains in total less than 0.5 wt. %, based on the total weight of aniline, of one or more compounds which contain at least one carbonyl group or of one or more compounds that are formed by reaction of these compounds which contain at least one carbonyl group with aniline. | 2009-09-24 |
20090240078 | MULTIFUNCTIONAL ALCOHOLS OBTAINED FROM CARDANOL, MULTIFUNCTIONAL ACRYLIC CROSSLINKER AND PENDANT PHOSPHOROUS FLAME RETARDANT DERIVATIVES THEREOF - Multifunctional alcohols, polyols derived from cardanol containing at least 3 hydroxyl groups are disclosed. Such alcohols allow for synthesis of multifunctional crosslinkers such as acrylates, epoxies, and vinyl ethers and flame retardants such as >phosphates. The multifunctional alcohols or polyols can be used in polyurethanes and polycarbonates. The multifunctional crosslinkers can be used in optical coating and waveguide compositions to increase curing speed and crosslink density. The multifunctional phosphates can be used in flame resistant plastics as the highly pendant phosphorus containing phosphate non-halogen flame retardant additives. | 2009-09-24 |
20090240079 | Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases - The present invention relates to a pharmaceutical composition useful for treating or preventing inflammatory disease and cell damage, and a method for treating or preventing inflammatory disease and cell damage. The present invention uses the 2-hydroxybenzoic acid derivative represented by the specific chemical formula or its pharmaceutically acceptable salt. The compound of the present invention is useful for treating or preventing cell damage and inflammatory disease including gastritis, gastric ulcer, pancreatitis, colitis, arthritis, diabetes, arteriosclerosis, nephritis, hepatitis, Alzheimer's disease, Parkinson's disease and Lou Gehrig's disease. | 2009-09-24 |
20090240080 | PROCESS FOR THE PREPARATION OF CETP(1) - The present invention relates to a process for the preparation of 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid which is useful as an intermediate in the preparation of pharmaceutical active compounds. | 2009-09-24 |
20090240081 | Process for converting alkanes to unsaturated carboxylic acids - The present invention relates to an improved process for the conversion of alkanes to unsaturated carboxylic acids. | 2009-09-24 |
20090240082 | Processes for Preparing Venlafaxine and Venlafaxine Hydrochloride of Form I - A process for preparing venlafaxine in a high yield as well as processes for producing venlafaxine hydrochloride of form I having a very hight polymorphic purity are described. | 2009-09-24 |
20090240083 | Preparation Method of 2, 6-Dichlor-4-Trifluoromethyl Aniline - This invention is involved with a preparation method of 2,6-dichlor-4-trifluoromethyl aniline. With this process, 4-chlorotrifluoromethyl benzene is used as the starting material and subjected to halogenation reaction and ammoniation reaction and through separation of reaction products the desired 2,6-dichlor-4-trifluoromethyl aniline is obtained. In addition, ammonia is recovered from the surplus ammonia water in ammoniation reaction. This applied invention in characterized by simple process, cheap and easy-available raw materials, high reaction yield and friendly environment. | 2009-09-24 |
20090240084 | METHOD FOR PRODUCING ETHYLENE AMINES ETHANOL AMINES FROM MONOETHYLENE GLYCOL (MEG) - A process for preparing ethylene amines and ethanolamines by hydrogenative amination of monoethylene glycol and ammonia in the presence of a catalyst, wherein the process is carried out in two process stages in which | 2009-09-24 |
20090240085 | METHOD OF PRODUCING DIOL, POLYDIOL, SECONDARY ALCOHOL OR DIKETONE COMPOUND - The invention is a process of using, as a reducing agent, a 12CaO.7Al | 2009-09-24 |
20090240086 | Preparation of glycerol tert-butyl ethers - A process for making glycerol di-tert-butyl ethers is disclosed. In one aspect of the invention, glycerol and isobutylene react in the presence of a β-zeolite having a silicon to aluminum ratio greater than 150. In another aspect, the etherification is performed in the presence of a β-zeolite and added tert-butyl alcohol. Each process selectively provides glycerol di-tert-butyl ethers while reducing the generation of isobutylene dimers and trimers. Utilizing both aspects of the inventive process simultaneously affords a diether product mixture containing less than 5 wt. % of isobutylene oligomers. | 2009-09-24 |
20090240087 | Process for Producing Optically Active Fluorobenzyl Alcohol - A fluorine-containing benzaldehyde is reacted with an alkyl Grignard reagent to convert it to a magnesium alkoxide of racemic, fluorine-containing, benzyl alcohol, and subsequently the magnesium alkoxide is reacted with phthalic anhydride to obtain a phthalate half ester of racemic, fluorine-containing, benzyl alcohol, and the half ester is optically resolved by optically active 1-phenylethylamine, and then the ester group is hydrolyzed, thereby producing an optically active, fluorine-containing, benzyl alcohol. | 2009-09-24 |
20090240088 | Biomass treatment process and system - The present invention provides processes and systems for treating biomass and, e.g., making biofuels, such as bioethanol, from the biomass. More particularly, one process according to the present invention includes (a) inducing at least a first portion of a composition containing biomass and a working fluid to flow into a passage of a fluid processing apparatus, (b) injecting a high velocity transport fluid into the composition through a nozzle communicating with the passage of the fluid processing apparatus, whereby the transport fluid applies a shear force to the composition such that the working fluid is atomised and a vapour and droplet flow regime is formed downstream of the nozzle, (c) condensing the vapour and droplet flow regime, (d) transferring the composition to a first holding vessel, and (e) holding the composition in the first holding vessel at a first predetermined temperature for a first predetermined period of time, wherein a liquefaction enzyme is added to the composition prior to or during the process. Thereafter, the composition may be further processed to form a biofuel, such as, e.g., bioethanol. | 2009-09-24 |
20090240089 | METHOD OF HYDRODECHLORINATION TO PRODUCE DIHYDROFLUORINATED OLEFINS - Disclosed herein is a process for the preparation of fluorine-containing olefins comprising contacting a chlorofluoroalkene with hydrogen in the presence of a catalyst at a temperature sufficient to cause replacement of the chlorine substituents with hydrogen. Also disclosed is a catalyst composition for the hydrodechlorination of chlorofluoroalkenes comprising copper metal deposited on a support. | 2009-09-24 |
20090240090 | INTEGRATED PROCESS TO PRODUCE 2,3,3,3-TETRAFLUOROPROPENE - A method for preparing 2,3,3,3-tetrafluoroprop-1-ene comprising (a) providing a starting composition comprising at least one compound having a structure selected from Formulae I, II and III: | 2009-09-24 |
20090240091 | SEPARATION AND/OR RECOVERY OF PROPYL BROMIDE - Described is a process for separating an organic phase comprising mainly propyl bromide from a crude reaction mixture formed by free-radical catalyzed hydrobromination of propylene with hydrogen bromide. The process comprises (A) feeding cold water into an upper or mid-portion of a packed column; (B) concurrently feeding the crude reaction mixture into an upper portion and/or mid-portion of the column so that the water contacts the crude reaction mixture; to form a mixture of (i) an acidic aqueous phase comprising aqueous hydrogen bromide and (ii) an organic phase comprising propyl bromide; (C) withdrawing the resultant phases from said column, at a rate comparable to the feeds being made into the column; and (D) separating the phases to form an upper acidic aqueous phase comprising aqueous hydrogen bromide superposed on a lower liquid organic phase comprising propyl bromide, and separating these upper and lower phases from each other. | 2009-09-24 |
20090240092 | ORTHO-NITROSOPHENOLS AS POLYMERIZATION INHIBITORS - Disclosed herein is a method for inhibiting the premature polymerization of ethylenically unsaturated monomers comprising adding to said monomers an effective amount of at least one nitroso inhibitor of the structure: | 2009-09-24 |
20090240093 | PROCESS FOR PRODUCTION OF AROMATIC COMPOUND - An aromatic compound, particularly benzene, is stably produced in the presence of a catalyst from a lower hydrocarbon having 2 or more carbon atoms, particularly from an ethane-containing gas composition such as ethane gas and natural gas. Disclosed is a process for producing an aromatic compound by reacting ethane or an ethane-containing raw gas in the presence of a catalyst. The catalyst may comprise molybdenum carried on metallosilicate such as H-type ZSM-5H or H-type MCM-22. In the reaction, the temperature is from 550 to 750° C., preferably not lower than 600° C. and not higher than 680° C. Additionally, the raw gas further contains methane and hydrogen is added thereto, thereby improving the production efficiency and stability. | 2009-09-24 |
20090240094 | Method for the Production of Propene from Propane - The invention relates to a process for preparing propene from propane, comprising the steps:
| 2009-09-24 |
20090240095 | SYSTEMS AND METHODS FOR DELIVERING RADIATION THERAPY - Described here are conformable brachytherapy applicators. The conformable brachytherapy applicators generally follow the contour of tissue surfaces so that distances between radiation sources and target tissues can be precisely determined and radiation dose clouds can be readily shaped. Systems and methods for using the conformable brachytherapy applicators are also described. | 2009-09-24 |
20090240096 | MAGNETIC CORE FOR MEDICAL PROCEDURES - The inventive technique includes a system, method and device for treating a patient. The device includes a magnetic device having a core created by a binder process having a relatively low temperature. The device further includes a conductor in electrical communication with the core. | 2009-09-24 |
20090240097 | IMPLANTABLE TWO-CHAMBER SYSTEM FOR SUPPORTING THE LEFT VENTRICLE OF THE HEART - Disclosed is an implantable two-chamber system for supporting the left ventricle of the heart. Each of the two pumping chambers ( | 2009-09-24 |
20090240098 | Patient carestation - A patient carestation for providing care to a patient including at least one environmental sensor sensing information concerning the environment surrounding the patient and providing electronic signals indicative of that environment. There are also physiological sensors sensing information relating to physiological conditions of the patient other than skin temperature and providing electronic signals indicative of physiological conditions of the patient. There may also be therapeutic sensors providing data based on therapy administered by peripheral apparatus and an input receiving patient information. A signal processor receives the signals from the physiological sensors, the environmental sensor, the therapeutic sensor and the patient information input and combines those signals into an integrated combination of signals for use by the caregiver. The integrated combination of signals can be used in a smart alarm or to generally appraise the caregiver at a central location as to the status of the patient. | 2009-09-24 |
20090240099 | BI-MODAL COCHLEA STIMULATION - An improved implantable hearing instrument and associated method utilize a transducer to mechanically stimulate a patient's cochlea (e.g. via the round window or oval window) in response to a first electrical drive signal, and a supply electrode to electrically stimulate the patient's cochlea in response to a second drive signal. The first and second drive signals may be provided to affect mechanical stimulation across a first predetermined frequency range and electrical stimulation across a second predetermined frequency range, respectively, wherein the predetermined frequency ranges are at least partially non-overlapping. In one embodiment an electromechanical transducer, having the supply member supportably interconnect thereto, may be selectively positioned via a mounting member fixedly interconnected to a patient's skull. The supply electrode may define a distal tip that is supportably interconnected to a vibratory member of the electromechanical transducer. In another embodiment, an implantable transducer may be employed that includes an external housing and an active transducer element located within an internal chamber of the external housing for receiving the first electrical signal. Further, the supply electrode may be one of electrically connected to and defined by at least an electrically-conductive portion of the external housing of the transducer. | 2009-09-24 |
20090240100 | Method for controlling flow of intestinal contents in a patient's intestines - There is provided a method for controlling a flow of intestinal contents in the intestinal passageway of a patient's intestines. The method comprises gently constricting (i.e., without substantially hampering the blood circulation in the intestinal tissue wall) at least one portion of the intestinal tissue wall to influence the flow in the intestinal passageway, and stimulating the constricted wall portion to cause contraction of the wall portion to further influence the flow in the intestinal passageway. The method can be used for restricting or stopping the flow in the intestinal passageway, or for actively moving the fluid in the intestinal passageway, with a low risk of injuring the intestines. | 2009-09-24 |
20090240101 | DISSOLVABLE PROTECTIVE TREATMENT FOR AN IMPLANTABLE SUPPORTIVE SLING - The invention provides, in one embodiment, a sling assembly including an implantable supportive sling and a biocompatible dissolvable protective treatment on at least a portion of the sling. | 2009-09-24 |
20090240102 | Apparatus and method for repairing vaginal reconstruction - Described are pelvic implants for treating vaginal prolapse, systems including the described pelvic implants, and methods of using the described implants and systems. | 2009-09-24 |
20090240103 | Elongation Resistant Fabric and Devices - An elongation resistant fabric, devices, and methods can include an elongation resistant yam laid in a knit structure of the fabric between knit loops in selected adjacent wales and partially about the loop in one adjacent wale in predetermined courses. In this manner, the fabric can be adapted to resist elongation in a walewise direction along the length of the fabric. The elongation resistant fabric can be a mesh fabric. In a mesh fabric, the size and a shape of pores in the fabric can be maintained when the fabric is pulled in the walewise direction. The elongation resistant yam can have a diameter larger than the individual diameters of other yarns in the fabric. The elongation resistant yarn can be, for example, a monofilament yarn, such as a polypropylene or polyester monofilament yarn. | 2009-09-24 |
20090240104 | Surgical Articles and Methods for Treating Pelvic Conditions - An implant, insertion tool, combinations, and associated methods, that involve placement of a self-fixating tip at tissue of the pelvic region, wherein an insertion tool includes one or more of an aperture for engaging a guide and an extension guard, the method optionally allowing for initial placement of a self-fixating tip at tissue of the pelvic region and adjustment of the location of the self-fixating tip. A threading guide is provided to assist in threading the guide through the aperture. An anchor also provided to with a retaining member to retain the anchor in tissue. | 2009-09-24 |
20090240105 | Endoscope & tools for applying sealants and adhesives and intestinal lining for reducing food absorption - A first part of the inventive instrument comprises an insertion and removal device in the form of an endoscope which may be inserted through the mouth, pharynx, esophagus and stomach into the small intestine. The inside lumen of the endoscope contains two extendable tools. One extendable tool has a balloon on its end, which may be inflated and deflated. The other extendable tool contains optical fibers for photopolymerizing adhesives and sealants. The second part of the inventive instrument comprises a tubular lining for implantation in and lining of the small intestine, to prevent food from being absorbed into the villi. The lining is anchored in position by means of medical-grade adhesives that are contained on or applied to a mesh sleeve on one end of the lining. The adhesive-coated sleeve is then expanded and glued to the intestine. In operation the lining expands outwardly as digesting food chemicals enter the lining. This allows the normal bodily peristalsis to squeeze the food chemicals through the lining. An alternate tool for an endoscope may be used to apply a coating of biodegradable sealant to the walls of the small intestine to restrict food absorption. Implanting the lining into the intestine or coating the intestine with sealant can be accomplished with no or minimal surgery. | 2009-09-24 |
20090240106 | Endoscope With a Stimulating Electrode For Peripheral Nerve Blocks Under Direct Vision - A nerve blocking endoscopic apparatus is disclosed having a stimulating electrode disposed at its distal end to aid in proper identification and placement of the apparatus adjacent a nerve to be blocked and to methods for making and using same. | 2009-09-24 |
20090240107 | APPARATUS FOR INTRODUCTION INTO TEST BODY - An apparatus for introduction into a test body includes a functional portion for obtaining information on an inside of a test body; a power source for supplying power for driving the functional portion; and an enclosed container for accommodating the functional portion and the power source. A cross-sectional shape orthogonal to a longitudinal direction of the enclosed container is an elliptical shape to make an outer shape small to alleviate a burden on a test subject during introduction into a body by swallowing or the like for test. | 2009-09-24 |
20090240108 | CAPSULE ENDOSCOPY SYSTEM AND METHOD OF CONTROLLING OPERATION OF CAPSULE ENDOSCOPE - A capsule endoscope captures an image from an imaging field as it travels through a tract of a patient and, at the same time, measures subject distances to multiple points in the imaging field. The capsule endoscope sends the captured image and information on the multi-point distances wirelessly to a data transceiver that the patient carries about. With reference to the multi-point distance information, a check zone of a limited distance range is determined in the imaging field, and the check zone is divided into small blocks. Image characteristic values are extracted from image data of each individual small block, and compared with the image characteristic values of other small blocks, to examine similarity between the small blocks. Those small blocks which are less similar to other small blocks are considered to constitute an area of concern, such as a lesion. | 2009-09-24 |
20090240109 | FLEXIBLE ENDOSCOPE WITH CORE MEMBER - A digital imaging endoscope with an elongated shaft has a core member for imparting flexibility and column strength to the shaft. The shaft extends distally from a proximal handle, and at least part of the shaft, or the entire shaft, comprises an inner member, the core member, and an outer member. The inner member defines at least three lumens. A first lumen is for receiving an instrument, a second lumen is for receiving one or more wires for connecting a digital imaging device at a distal portion of the shaft to a display unit, and a third lumen is for receiving the core member. The core member can occupy the space within the shaft that was traditionally occupied by a fiber optic bundle in non-digital imaging endoscopes. The outer member is disposed over the inner member of the shaft, and the outer member defines a lumen through which the inner member extends. | 2009-09-24 |
20090240110 | ENDOSCOPE - An insertion instrument which is connected to a manipulating head grip is composed of an elongated flexible tube section, an articular section and a rigid tip end section in series from a proximal end which is connected to the manipulating head grip. The articular section can be flexed in an arbitrary direction by way of a flexion control means which is provided on the manipulating head grip. A flexible tube straightening means is provided internally of the flexible tube section to straighten the same into a rectilinear form. The flexible tube straightening means is activated into a straightening action in interlinked relation with a flexing operation of the flexion control means. | 2009-09-24 |
20090240111 | Light Source and Lens Cleaner for Laparoscopic Surgery - An intraperitoneal cleaner to allow cleaning of a scope lens used in minimally invasive surgery is presented. Using existing super elastic alloys in combination with a standard spring, a purely mechanical cleaning action is provided, eliminating the reservoirs, vacuum pumps, or extra ports found in other cleaner designs. The scope body is inserted into the device prior to commencement of surgery, and the wiper of the cleaner rests just outside of the field of view of the lens of the scope. When debris or fluid obscures the field of view, a spring in the handle is compressed, allowing the cleaner to flex and provide a cleaning action. | 2009-09-24 |
20090240112 | Methods and Devices for Facilitating Visualization In a Surgical Environment - Devices and methods for visually confirming the positioning of a distal end portion of an illuminating device placed within a patient include inserting a distal end portion of an illuminating device internally into a patient, emitting light from the distal end portion of the illuminating device, observing transillumination resulting from the light emitted from the distal end portion of the illuminating device that occurs on an external surface of the patient, and correlating the location of the observed transillumination on the external surface of the patient with an internal location of the patient that underlies the location of observed transillumination, to confirm positioning of the distal end portion of the illuminating device. | 2009-09-24 |
20090240113 | DIARY-FREE CALORIMETER - An indirect calorimeter estimates nutritional caloric intake by periodically monitoring weight and sensing physical exercise (i.e., physiological data and/or motion data related to physical exertion), which can then be used in a calorimetry model derived from regression analysis of a population (e.g., linear regression, feed-forward neural network, Gaussian process, boosted regression tree, etc.). A strap-on user device for tracking exercise can detect one or more of heart rate, body temperature, skin resistance, motion/acceleration sensing (e.g., pedometer, accelerometer), velocity sensing (e.g., global positioning system (GPS)), and an intelligent, integrated exercise machine (e.g., treadmill, exercise bike, etc.). To gain further fidelity, the user can fine-tune the estimate by undergoing a journal-based routine for a relatively short period of time or clinical calorimetry measurement (e.g., respiratory calorimeter), thereby providing a baseline for resting or exercising metabolic rate. | 2009-09-24 |
20090240114 | BREAST CANCER DIAGNOSIS APPARATUS - A breast cancer diagnosis apparatus controls supply and flow rate of fluid to rapidly and effectively supply the fluid. As a result, time for diagnosing the breast cancer is shortened. Also, by preventing overflow or shortage of the fluid, the breast cancer diagnosis apparatus accurately diagnoses the breast cancer. A breast cancer diagnosis apparatus includes a fluid supply unit, and a supply control unit for controlling the fluid supplied from the fluid supply unit. | 2009-09-24 |
20090240115 | COMMUNITY BASED MANAGED HEALTH KIOSK SYSTEM FOR SOLICITING MEDICAL TESTING AND HEALTH STUDY PARTICIPANTS - The present invention is directed to community based managed health kiosk systems for the solicitation of patients for medical testing and health studies, and more particularly to facilitating a kiosk user's access to current and upcoming medical tests and trials that would be appropriate for the given user based upon kiosk health assessments. | 2009-09-24 |
20090240116 | TRIAGE BASED MANAGED HEALTH KIOSK SYSTEM - The present invention is directed to triage based managed health kiosk systems, and more particularly to facilitating a more automated approach to emergency triage situations through use of kiosk systems in combination with on-site health care professionals. The disclosed system allows a user to answer automated health assessment questions, provide health data, and consult with an on-site health care professional, and then receive a health care professional authorized triage assessment of the extent and relative urgency of care needed. | 2009-09-24 |
20090240117 | DATA ACQUISITION FOR MODULAR BIOMETRIC MONITORING SYSTEM - A modular system for acquiring biometric data includes a plurality of data acquisition modules configured to sample biometric data from at least one respective input channel at a data acquisition rate. A representation of the sampled biometric data is stored in memory of each of the plurality of data acquisition modules. A central control system is in communication with each of the plurality of data acquisition modules through a bus. The central control system is configured to collect data asynchronously, via the bus, from the memory of the plurality of data acquisition modules according to a relative fullness of the memory of the plurality of data acquisition modules. | 2009-09-24 |
20090240118 | MOBILE DEVICE AND SYSTEM FOR MONITORING & RECORDING BODY VITAL SIGNS - A method and apparatus is disclosed herein for monitoring vital signs using a health monitor embedded into a mobile device. In one embodiment, the apparatus comprises a mobile device having an embedded health monitor to take measurements of vital signs of an individual, to determine vital sign parameters from the measurements, and to transfer the vital sign parameters; and a computing system communicably coupled to the mobile device to store the vital sign parameters and to perform trend analysis on stored vital sign parameters and to provide feedback to the user or user specified persons and generate alarms. | 2009-09-24 |
20090240119 | Device and Method for Determining a Comparison Value of Biodata and for Recording Biodata - The method and the device are used for evaluating recorded measurement data. In particular, the use of the method and of the device makes it possible to detect the individual risk of a living being in respect of certain disease states and, if appropriate, to automatically evaluate correspondingly recognized risks in a device control. Measurement data in respect of heart-specific and/or circulation-specific parameters or respiration-specific parameters of a patient are preferably recorded and evaluated. The measurement data are determined over a defined period of time and the measurement data are evaluated taking into account the time information. A particularly effective implementation of the method can be based on pattern recognition in which individual patterns and/or sequence patterns are evaluated. | 2009-09-24 |
20090240120 | SYSTEMS AND METHODS FOR PROCESSING, TRANSMITTING AND DISPLAYING SENSOR DATA - Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices. | 2009-09-24 |
20090240121 | Intravascular sensor and insertion set combination - An intravascular sensor assembly insertable into an intravenous catheter, the sensor assembly includes a sheath having a sheath proximal end and a sheath distal end wherein an outer diameter of the sheath is sized to be substantially equal to the outer diameter of an insertion needle of the intravenous catheter, a hub sealingly connected to the sheath proximal end, the hub adapted for removably coupling to the intravenous catheter, a sensor disposed within the sheath, the sensor having a sensor shank with a shank distal end and a shank proximal end, a plurality of sensor elements including a working electrode with a reagent matrix disposed thereon, the reagent matrix comprising an enzyme capable of catalyzing a reaction involving a substrate for the enzyme and a reference electrode, the plurality of sensor elements disposed adjacent the shank distal end, a plurality of connector pads disposed at the shank proximal end where the plurality of connector pads are contained within the hub and the plurality of sensor elements are exposed adjacent the sheath distal end, and a plurality of elongated conductive elements where each of the plurality of conductive elements electrically couples one of the plurality of sensor elements to one of the plurality of connector pads, and a cable electrically coupled to the plurality of connector pads. | 2009-09-24 |
20090240122 | INTRAJUGULAR CATHETER - A catheter for insertion into a vascular system of a patient and for directing fluid flow includes a catheter body having a longitudinal axis and longitudinally spaced proximal and distal catheter ends with an intermediate catheter portion defined therebetween. An intermediate catheter outlet in the catheter body is located in the intermediate catheter portion and is spaced longitudinally from the proximal and distal catheter ends. A first lumen is defined within the catheter body and has longitudinally spaced proximal and distal first lumen ends with a reversing bend located therebetween, the first lumen providing fluid communication between the proximal catheter end and the intermediate catheter outlet. The reversing bend is located longitudinally between the intermediate catheter outlet and the distal catheter end. The reversing bend directs fluid flow to turn approximately 180° as the fluid flows through the first lumen. A method of using the catheter is also described. | 2009-09-24 |
20090240123 | DETERMINING RELATIVE BLOOD HEMATOCRIT LEVEL USING AN AUTOMATED INTEGRATED FLUID DELIVERY AND BLOOD ACCESS DEVICE - Devices and methods for determining the fluid characteristics of a blood sample may include the assessment of a pressure waveform of a fluid sample having a pre-determined volume passed through or out of a flow restrictor. The interface between the blood and other fluids in the tubing line of the blood monitoring system may also be assessed. These assessments may be used alone or in combination to generate estimates of other fluid characteristics, such as the hematocrit of a blood sample. This information may be used for the real-time determination of change of hematocrit levels in a patient's blood while the patient is being transfused with intravenous fluids or other vascular products, or to provide adjustment factors for other blood assays affected by the hematocrit or other blood parameters. | 2009-09-24 |
20090240124 | Systems and Methods for Measuring the Concentration of Analytes in the Human Eye - A method for determining the concentration of an analyte within a volume located between the cornea and the iris of an eye includes determining an index of refraction of a volume disposed between a cornea and an iris of an eye, the volume including an analyte. Based upon the index of refraction of said volume, the concentration of the analyte within the volume is determined. | 2009-09-24 |
20090240125 | INTEGRATED PULSE OXIMETRY SENSOR - In a medical pulse oximetry sensor ( | 2009-09-24 |